Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 494
Immune Disorders Drugs 208
Drug Discovery 169
Cardiovascular Drugs 165
Infectious Diseases Drugs 140
Biopharmaceuticals 131
Clinical Trials 128
Endocrine and Metabolic Disorders Drugs 113
Central Nervous System Drugs 107
Musculoskeletal Disorders Drugs 102
Pharmaceuticals 99
Hematological Drugs 85
Leukemia Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 64
Dermatological Drugs 59
Diabetes Drugs 57
Brain Cancer Drugs 50
Skin Cancer Drugs 50
Respiratory Drugs 45
Mental Disorders Drugs 44
Gastrointestinal Drugs 43
Lung Cancer Drugs 41
Drug Delivery 39
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 36
Pharmaceutical Manufacturing 33
Liver Cancer Drugs 30
Infusions and Injectables 30
Analgesics 27
Bladder Cancer Drugs 26
Antibiotics 26
Drugs by Therapeutic Area 25
Kidney Cancer Drugs 22
HIV/AIDS Drugs 21
Colon Cancer Drugs 20
Pancreatic Cancer Drugs 20
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Schizophrenia Drugs 17
Ovarian Cancer Drugs 16
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Breast Cancer Drugs 14
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Psoriasis Drugs 14
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Vaccines 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Alzheimer's Disease Drugs 8
Uterine Cancer Drugs 6
Company Reports 5
Pharmacoeconomics 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



275 reviews

2,539 Results (Page 105 of 127)
- Relevance
  Sort by

Brazil Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
76 Pages
Brazil

From

€2375EUR$2,680USD£2,045GBP

€2969EUR$3,350USD£2,557GBP

France Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
77 Pages
France

From

€2375EUR$2,680USD£2,045GBP

€2969EUR$3,350USD£2,557GBP

Germany Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
75 Pages
Germany

From

€2375EUR$2,680USD£2,045GBP

€2969EUR$3,350USD£2,557GBP

Mexico Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
74 Pages
Mexico

From

€2375EUR$2,680USD£2,045GBP

€2969EUR$3,350USD£2,557GBP

Japan Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
73 Pages
Japan

From

€2375EUR$2,680USD£2,045GBP

€2969EUR$3,350USD£2,557GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Israel Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
76 Pages
Israel

From

€2375EUR$2,680USD£2,045GBP

€2969EUR$3,350USD£2,557GBP

Turkey Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
82 Pages
Turkey

From

€2375EUR$2,680USD£2,045GBP

€2969EUR$3,350USD£2,557GBP

Bio-pharma Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

 Report
January 2025
97 Pages
Global

From

€3500EUR$4,231USD£3,120GBP

Intravitreal Injectables Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
118 Pages
Global

From

€3988EUR$4,500USD£3,434GBP

IgG4-Related Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1329EUR$1,500USD£1,145GBP

High Potency APIs Global Market Opportunities And Strategies To 2031

 Report
July 2022
230 Pages
Global

From

€4431EUR$5,000USD£3,816GBP

Cellular Immunotherapy Market Size, Share & Trends Analysis Report by Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy), by Indication (B-cell Malignancies, Prostate Cancer), by End-use, by Region, and Segment Forecasts, 2022-2030

 Report
July 2022
165 Pages
Global

From

€5273EUR$5,950USD£4,541GBP

Stroke Therapeutics Market 2021-2025

 Report
January 2022
120 Pages
Global

From

€2215EUR$2,500USD£1,908GBP

Heart Failure Drugs Market 2021-2025

 Report
January 2022
120 Pages
Global

From

€2215EUR$2,500USD£1,908GBP

Cancer Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
100 Pages
Global

From

€3323EUR$3,750USD£2,862GBP

Hematological Cancer (Blood Cancer) Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
100 Pages
Global

From

€3323EUR$3,750USD£2,862GBP

Cancer Immunotherapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
100 Pages
Global

From

€3323EUR$3,750USD£2,862GBP

Asia Pacific Multiple Myeloma Market Size, Share & Industry Trends Analysis Report By End User, By Disease Type (Active Multiple Myeloma and Smoldering Multiple Myeloma), By Drug Type, By Country and Growth Forecast, 2023-2029

 Report
April 2023
100 Pages
Asia Pacific

From

€1329EUR$1,500USD£1,145GBP

North America Multiple Myeloma Market Size, Share & Industry Trends Analysis Report By End User, By Disease Type (Active Multiple Myeloma and Smoldering Multiple Myeloma), By Drug Type, By Country and Growth Forecast, 2023-2029

 Report
April 2023
88 Pages
North America

From

€1329EUR$1,500USD£1,145GBP

LAMEA Multiple Myeloma Market Size, Share & Industry Trends Analysis Report By End User, By Disease Type (Active Multiple Myeloma and Smoldering Multiple Myeloma), By Drug Type, By Country and Growth Forecast, 2023-2029

 Report
April 2023
99 Pages
Middle East, Africa

From

€1329EUR$1,500USD£1,145GBP

2,539 Results (Page 105 of 127)
- 1
- 103
- 104
- 105
- 106
- 107

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.